Venus Concept Inc. to Present at the H.C. Wainwright Annual Global LifeSciences Conference on March 9th
Venus Concept, a leading global medical aesthetic technology firm, announced its participation in the H.C. Wainwright Annual Global Life Sciences Conference on March 9-10, 2021. The company's management will present virtually, with the presentation available on-demand starting March 9 at 7:00 a.m. Eastern Time. The audio webcast can be accessed on the company’s investor relations website, and an archive will be available post-conference. Venus Concept operates in over 60 countries, offering a broad range of minimally invasive aesthetic technologies and hair restoration systems.
- None.
- None.
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will attend and present at the H.C. Wainwright Annual Global LifeSciences Conference, which is being held virtually from March 9th-10th. Management’s presentation will be available on-demand beginning on Tuesday, March 9th at 7:00 a.m. Eastern Time.
An audio webcast of the presentations will be accessible under the “Events” section of the Company's investor relations website at https://ir.venusconcept.com/. An archive of the webcast will be available for replay following the conference.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 20 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Heal, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems includes NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.
FAQ
What is the date of Venus Concept's presentation at the H.C. Wainwright Conference?
Where can I access the audio webcast of Venus Concept's presentation?
What is the stock symbol for Venus Concept?
What technologies does Venus Concept offer?
In how many countries does Venus Concept operate?
